Celularity
CELU
73 hedge funds and large institutions have $44.3M invested in Celularity in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 15 closing their positions.
2,568% more call options, than puts
Call options by funds: $1.07M | Put options by funds: $40K
56% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 16
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
1% more funds holding
Funds holding: 72 → 73 (+1)
0.1% less ownership
Funds ownership: 2.46% → 2.36% (-0.1%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
45% less capital invested
Capital invested by funds: $81.1M → $44.3M (-$36.8M)
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$375K |
| 2 |
BlackRock
New York
|
+$254K |
| 3 |
D.E. Shaw & Co
New York
|
+$140K |
| 4 |
BFO
Biltmore Family Office
Charlotte,
North Carolina
|
+$106K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
+$102K |
Top Sellers
CELU Hedge Fund Activity: Q4 2022 in Review
73 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q4 2022, worth a combined $44.3M — down 45% from $81.1M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CELU positions and 15 closed out — a net gain of 2 holders — while 25 added to existing stakes and 16 trimmed.
The largest buyer was State Street, adding an estimated $375K. The largest seller was B. Riley Financial, exiting entirely with an estimated $870K sold.
- 73 institutional investors held Celularity (CELU) as of Q4 2022, up from 72 in Q3 2022.
- Funds reported $44.3M of Celularity stock for Q4 2022, down 45% quarter-over-quarter.
- 17 funds opened new Celularity positions in Q4 2022 and 15 closed out, a net change of +2 holders.
- The largest Celularity buyer in Q4 2022 was State Street, an estimated $375K added.
- The largest Celularity seller in Q4 2022 was B. Riley Financial, an estimated $870K sold.
Based on aggregated 13F filings for Q4 2022.